Iktos raised €16M in a Series A round in Mar 2023. The company is based in Paris, France. Investors in the round: Debiopharm Innovation Fund, M Ventures, Omnes Capital. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €16M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.